Impact of intracellular beta-amyloid in transgenic animals and cell models.
The present commentary based on cell and animal models of intracellular beta-amyloid (iAbeta) expression indicates that low levels of microscopically undetectable iAbeta could have a physiological role in the modulation of the cyclic AMP response element (CRE)-dependent gene expression and, as a consequence, a positive influence on synaptic plasticity (the 'good' Abeta?). On the other hand, high levels of iAbeta resembling the pathological and microscopically visible accumulation of this amyloid peptide, akin to that observed in Down syndrome and Alzheimer's disease, disrupt CRE-regulated gene expression, therefore compromising the protein synthesis-dependent component of long-term potentiation (the 'bad' Abeta?). Moreover, intracellular pathology would be independent and additive to the toxic effects of the extracellular Abeta burden.
Cuello
A Claudio
AC
Department of Pharmacology and Therapeutics, McGill University, Montreal, Que., Canada. claudio.cuello@mcgill.ca
Canneva
Fabio
F
D016229:Amyloid beta-Peptides / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism* / Q000502:physiology; D000818:Animals; D030801:Animals, Genetically Modified / Q000235:genetics*; D002478:Cells, Cultured; D006801:Humans; D007424:Intracellular Fluid / Q000378:metabolism* / Q000502:physiology; D009474:Neurons / Q000378:metabolism* / Q000473:pathology*
D016229:Amyloid beta-Peptides